The continuation vehicle secured approximately $2.3 billion in commitments and was led by CVC Secondary Partners.

Cerberus Capital Management, L.P. (together with its affiliates, "Cerberus"), a global alternative investment firm, today announced the closing of a single-asset continuation vehicle for Subsea ...

If you talk to people from the winners of Canada’s Greenest Employers (2026), you’ll often hear the refrain, “Sustainability ...

The Brown County Quality of Life Board (QOLAB) began in early 2025 as an informal gathering of diverse community leaders at ...

H7 Technologies closed US $32M Series B with Asahi Kasei, Circular Innovation Fund joining Fine Structure Ventures, BHP Ventures, other investors. Fasken served as pH7’s legal counsel.

According to the latest market analysis by Future Market Insights, the global central venous catheter market is witnessing sustained growth driven by the rising prevalence of chronic diseases, ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.

H7 Technologies announced the oversubscribed final closing of its Series B financing round, as global demand for critical ...

Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...